Drug Type Monoclonal antibody |
Synonyms MG ZG122, MGZG122 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Phase 1 | CN | 06 Feb 2023 | |
Pulmonary Disease, Chronic Obstructive | IND Approval | CN | 25 Jul 2022 | |
Dermatitis, Atopic | IND Approval | CN | 31 May 2022 | |
Sinusitis | IND Approval | CN | 31 May 2022 |